Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bor Vratanar

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biometrical Journal. Biometrische Zeitschrift|June 6, 2023
Evaluating cancer screening programs using survival analysisBor Vratanar, Maja Pohar Perme
Helicobacter|January 7, 2026
An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and AdolescentsAnja Šterbenc, Bor Vratanar, Eva Miler Mojškerc, et al.
Cancers|March 13, 2025
Evaluation of the Slovenian Breast Cancer Screening Programme: Years of Life Gained and Avoided DeathsSonja Tomšič, Vesna Zadnik, Maja Pohar Perme, et al.
Life (Basel, Switzerland)|October 23, 2021
COVID-19 in Slovenia, from a Success Story to Disaster: What Lessons Can Be Learned?Nina Ružić Gorenjec, Nataša Kejžar, Damjan Manevski, et al.
Journal of Clinical Medicine|December 24, 2021
Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings?Tanja Belčič Mikič, Bor Vratanar, Tadej Pajič, et al.
Journal of Clinical Medicine|October 15, 2020
Prognostic Factor Analysis of Visual Outcome after Vitrectomy for Rhegmatogenous Retinal DetachmentPolona Zaletel Benda, Bor Vratanar, Goran Petrovski, et al.
Journal of Clinical Medicine|October 27, 2022
The Relative Preservation of the Central Retinal Layers in Leber Hereditary Optic NeuropathySanja Petrovic Pajic, Luka Lapajne, Bor Vratanar, et al.
Radiology and Oncology|March 24, 2026
Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell RecoveryTomaz Jurca, Lucka Boltezar, Miha Orazem, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biometrical Journal. Biometrische Zeitschrift|June 6, 2023
Evaluating cancer screening programs using survival analysisBor Vratanar, Maja Pohar Perme
Helicobacter|January 7, 2026
An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7-Day Triple Therapy With Bismuth Versus 14-Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and AdolescentsAnja Šterbenc, Bor Vratanar, Eva Miler Mojškerc, et al.
Cancers|March 13, 2025
Evaluation of the Slovenian Breast Cancer Screening Programme: Years of Life Gained and Avoided DeathsSonja Tomšič, Vesna Zadnik, Maja Pohar Perme, et al.
Life (Basel, Switzerland)|October 23, 2021
COVID-19 in Slovenia, from a Success Story to Disaster: What Lessons Can Be Learned?Nina Ružić Gorenjec, Nataša Kejžar, Damjan Manevski, et al.
Journal of Clinical Medicine|December 24, 2021
Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings?Tanja Belčič Mikič, Bor Vratanar, Tadej Pajič, et al.
Journal of Clinical Medicine|October 15, 2020
Prognostic Factor Analysis of Visual Outcome after Vitrectomy for Rhegmatogenous Retinal DetachmentPolona Zaletel Benda, Bor Vratanar, Goran Petrovski, et al.
Journal of Clinical Medicine|October 27, 2022
The Relative Preservation of the Central Retinal Layers in Leber Hereditary Optic NeuropathySanja Petrovic Pajic, Luka Lapajne, Bor Vratanar, et al.
Radiology and Oncology|March 24, 2026
Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-Cell RecoveryTomaz Jurca, Lucka Boltezar, Miha Orazem, et al.
Pageof 1